Sodium valproate: Sanofi is indicted in France for failing to warn adequately about birth defects

The pharmaceutical giant Sanofi has been charged in France with failing to adequately warn pregnant women that its epilepsy drug Depakine (sodium valproate) carries a risk of birth…


Read Original Article: Sodium valproate: Sanofi is indicted in France for failing to warn adequately about birth defects »